Investment Rating - The report maintains a "Buy" rating for Wanhua Chemical [5] Core Views - The company's performance in the first half of 2024 met expectations, with revenue of 97.067 billion yuan, a year-on-year increase of 10.77%, and a net profit of 8.174 billion yuan, a year-on-year decrease of 4.6% [5] - The polyurethane segment is seeing new capacity being released, while the petrochemical segment is supported by high costs but faces demand pressure [5][8] - The demand for refrigerators and freezers remains high, with Q2 production and sales maintaining elevated levels [5][13] - Short-term demand is expected to be weak due to seasonal factors, but supply-side support is strong, indicating potential recovery in the upcoming peak season [5][20] - The company is focused on high R&D investment and capital expenditure to support long-term growth and aims to become a leader in the global chemical industry [5][22][23] Summary by Sections Financial Performance - In H1 2024, the company achieved operating revenue of 97.067 billion yuan, with a net profit of 8.174 billion yuan, reflecting a year-on-year decrease of 4.6% [5][6] - The Q2 revenue was 50.906 billion yuan, a year-on-year increase of 11.42% [5] Business Segments - Polyurethane Segment: Revenue reached approximately 17.95 billion yuan in Q2, with a year-on-year increase of 5.1% [8] - Petrochemical Segment: Revenue was 21.061 billion yuan in Q2, with a year-on-year increase of 17.4% [8] - New Materials Segment: The segment continues to expand, with Q2 production increasing by 29.3% year-on-year [9] Market Demand - The refrigerator industry, which accounts for a significant portion of MDI demand, saw production of 26.889 million units in Q2 2024, a year-on-year increase of 7% [13] - Domestic MDI demand is improving, supported by strong export performance [17] Future Outlook - The company anticipates a recovery in demand as the peak season approaches, despite current seasonal weaknesses [20] - By 2025, Wanhua Chemical's global market share in MDI is expected to approach 40%, benefiting large-scale enterprises [20] R&D and Capital Expenditure - The company maintains a high level of R&D investment, approximately 4 billion yuan annually, to support technological advancements [22][23] - Significant capital expenditures are planned to accelerate the industrialization of technology reserves [22][23]
万华化学:业绩基本符合预期,在建产能陆续释放,海外装置扰动支撑出口需求